Manulife (Manufacturers Life Insurance)’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $997K | Buy |
111,300
+5,531
| +5% | +$49.6K | ﹤0.01% | 1823 |
|
|
2025
Q1 | $793K | Buy |
105,769
+2,238
| +2% | +$16.8K | ﹤0.01% | 1915 |
|
|
2024
Q4 | $779K | Sell |
103,531
-195,621
| -65% | -$1.47M | ﹤0.01% | 2015 |
|
|
2024
Q3 | $2.27M | Buy |
299,152
+86,571
| +41% | +$658K | ﹤0.01% | 1506 |
|
|
2024
Q2 | $1.31M | Buy |
212,581
+113,152
| +114% | +$699K | ﹤0.01% | 1697 |
|
|
2024
Q1 | $505K | Buy |
99,429
+1,235
| +1% | +$6.27K | ﹤0.01% | 2209 |
|
|
2023
Q4 | $588K | Buy |
98,194
+191
| +0.2% | +$1.14K | ﹤0.01% | 2106 |
|
|
2023
Q3 | $694K | Buy |
98,003
+21,077
| +27% | +$149K | ﹤0.01% | 1964 |
|
|
2023
Q2 | $542K | Buy |
76,926
+2,497
| +3% | +$17.6K | ﹤0.01% | 1985 |
|
|
2023
Q1 | $621K | Buy |
74,429
+346
| +0.5% | +$2.89K | ﹤0.01% | 1874 |
|
|
2022
Q4 | $850K | Buy |
74,083
+631
| +0.9% | +$7.24K | ﹤0.01% | 1693 |
|
|
2022
Q3 | $925K | Sell |
73,452
-1,285
| -2% | -$16.2K | ﹤0.01% | 1642 |
|
|
2022
Q2 | $791K | Buy |
74,737
+962
| +1% | +$10.2K | ﹤0.01% | 1757 |
|
|
2022
Q1 | $1.2M | Sell |
73,775
-16,950
| -19% | -$276K | ﹤0.01% | 1673 |
|
|
2021
Q4 | $1.26K | Buy |
90,725
+138
| +0.2% | +$2 | ﹤0.01% | 1692 |
|
|
2021
Q3 | $1.3M | Sell |
90,587
-8,903
| -9% | -$128K | ﹤0.01% | 1673 |
|
|
2021
Q2 | $1.57M | Buy |
99,490
+426
| +0.4% | +$6.74K | ﹤0.01% | 1719 |
|
|
2021
Q1 | $1.01M | Sell |
99,064
-7,088
| -7% | -$72.1K | ﹤0.01% | 1872 |
|
|
2020
Q4 | $791K | Buy |
106,152
+6,400
| +6% | +$47.7K | ﹤0.01% | 1953 |
|
|
2020
Q3 | $343K | Buy |
99,752
+7,333
| +8% | +$25.2K | ﹤0.01% | 2202 |
|
|
2020
Q2 | $460K | Sell |
92,419
-5,731
| -6% | -$28.5K | ﹤0.01% | 2008 |
|
|
2020
Q1 | $196K | Buy |
98,150
+27,330
| +39% | +$54.6K | ﹤0.01% | 2334 |
|
|
2019
Q4 | $244K | Sell |
70,820
-1,453
| -2% | -$5.01K | ﹤0.01% | 2461 |
|
|
2019
Q3 | $229K | Hold |
72,273
| – | – | ﹤0.01% | 2489 |
|
|
2019
Q2 | $274K | Buy |
72,273
+473
| +0.7% | +$1.79K | ﹤0.01% | 2414 |
|
|
2019
Q1 | $585K | Buy |
71,800
+4,151
| +6% | +$33.8K | ﹤0.01% | 2000 |
|
|
2018
Q4 | $546K | Sell |
67,649
-5,540
| -8% | -$44.7K | ﹤0.01% | 1914 |
|
|
2018
Q3 | $558K | Sell |
73,189
-3,360
| -4% | -$25.6K | ﹤0.01% | 2199 |
|
|
2018
Q2 | $438K | Buy |
76,549
+1,044
| +1% | +$5.97K | ﹤0.01% | 2495 |
|
|
2018
Q1 | $360K | Sell |
75,505
-1,236
| -2% | -$5.89K | ﹤0.01% | 2574 |
|
|
2017
Q4 | $377K | Buy |
76,741
+13,760
| +22% | +$67.6K | ﹤0.01% | 2511 |
|
|
2017
Q3 | $330K | Sell |
62,981
-135
| -0.2% | -$707 | ﹤0.01% | 2578 |
|
|
2017
Q2 | $351K | Buy |
63,116
+3,774
| +6% | +$21K | ﹤0.01% | 2558 |
|
|
2017
Q1 | $498K | Buy |
59,342
+7,275
| +14% | +$61.1K | ﹤0.01% | 2194 |
|
|
2016
Q4 | $329K | Sell |
52,067
-1,916
| -4% | -$12.1K | ﹤0.01% | 2408 |
|
|
2016
Q3 | $238K | Sell |
53,983
-1,246
| -2% | -$5.49K | ﹤0.01% | 2639 |
|
|
2016
Q2 | $157K | Buy |
55,229
+6,507
| +13% | +$18.5K | ﹤0.01% | 2904 |
|
|
2016
Q1 | $133K | Buy |
48,722
+626
| +1% | +$1.71K | ﹤0.01% | 2887 |
|
|
2015
Q4 | $496 | Buy |
48,096
+498
| +1% | +$5 | ﹤0.01% | 2031 |
|
|
2015
Q3 | $543 | Sell |
47,598
-186,733
| -80% | -$2.13K | ﹤0.01% | 1945 |
|
|
2015
Q2 | $3.5K | Buy |
234,331
+187,808
| +404% | +$2.8K | ﹤0.01% | 1229 |
|
|
2015
Q1 | $420 | Buy |
46,523
+1,581
| +4% | +$14 | ﹤0.01% | 2196 |
|
|
2014
Q4 | $546 | Sell |
44,942
-1,031
| -2% | -$13 | ﹤0.01% | 1924 |
|
|
2014
Q3 | $449 | Buy |
45,973
+1,371
| +3% | +$13 | ﹤0.01% | 2056 |
|
|
2014
Q2 | $568K | Buy |
44,602
+42,866
| +2,469% | +$546K | ﹤0.01% | 1958 |
|
|
2014
Q1 | $18 | Buy |
1,736
+115
| +7% | +$1 | ﹤0.01% | 3307 |
|
|
2013
Q4 | $12 | Buy |
1,621
+21
| +1% | – | ﹤0.01% | 3328 |
|
|
2013
Q3 | $12 | Hold |
1,600
| – | – | ﹤0.01% | 3234 |
|
|
2013
Q2 | $2K | Buy |
+1,600
| New | +$2K | ﹤0.01% | 3397 |
|